This looks very promising for Provenge and PC Patients. From the article "Preclinical animal studies in Khleif’s lab found that the combination of Provenge with these two other drugs led to a significant increase in survival and complete tumor regression in more than 50 percent of mice."
I just saw that article...sounds very promising w/ tumor regression in more than 50 percent of mice. Wow!! Sounds like excellent news. I am a long-term holder and am losing a bunch of money but just bought 4000 more shares to trade in the low 4's. I almost sold them for a 2000 profit today but decided to hang on since it closed at the HOD price.